Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 57 citing articles:

Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179
Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
Sara Scarpini, Francesca Morigi, Ludovica Betti, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 551-551
Open Access | Times Cited: 63
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
Eleanor C. Semmes, Itzayana G. Miller, Courtney E. Wimberly, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 49
Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review
Ivana Grgić, Lana Gorenec
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 2, pp. 49-49
Open Access | Times Cited: 8
Structure of the Kaposi’s sarcoma-associated herpesvirus gB in post-fusion conformation
Fumiaki Ito, James Zhen, Guodong Xie, et al.
Journal of Virology (2025)
Open Access | Times Cited: 1
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
Cody S. Nelson, Jennifer A. Jenks, Norbert Pardi, et al.
Journal of Virology (2020) Vol. 94, Iss. 9
Open Access | Times Cited: 50
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 6
An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection
Kingshuk Panda, Deepti Parashar, Rajlakshmi Viswanathan
Viruses (2023) Vol. 15, Iss. 6, pp. 1358-1358
Open Access | Times Cited: 15
Human cytomegalovirus infection activates NLRP3 inflammasome by releasing mtDNA into the cytosol in human THP‐1 cells
Xi Xu, Junwen Cai, Xiaoming Wang, et al.
Microbiology and Immunology (2023) Vol. 67, Iss. 6, pp. 303-313
Open Access | Times Cited: 13
HCMV Envelope Glycoprotein Diversity Demystified
Mathilde Foglierini, Jessica Marcandalli, Laurent Perez
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 36
Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease
Lizette E. Rios, Emilia Campos, Ramkumar Menon, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1866, Iss. 3, pp. 165591-165591
Open Access | Times Cited: 36
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 22
Primary, Secondary, and Tertiary Prevention of Congenital Cytomegalovirus Infection
Pauline Sartori, Charles Egloff, Najeh Hcini, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 819-819
Open Access | Times Cited: 12
RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translation
Rebekah J. Dickmander, Erik M. Lenarcic, John D. Sears, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access
Clinical and Immunologic Impact of CMV Coinfection Among Children Living With HIV in Canada
Yves Fougère, Jason Brophy, Michael Hawkes, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
Michela Perotti, Laurent Perez
Viruses (2019) Vol. 12, Iss. 1, pp. 35-35
Open Access | Times Cited: 33
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
Cody S. Nelson, Ilona Baraniak, Daniele Lilleri, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. Supplement_1, pp. S45-S59
Open Access | Times Cited: 33
Cytomegalovirus as an immunomodulator across the lifespan
Eleanor C. Semmes, Jillian H. Hurst, Kyle M. Walsh, et al.
Current Opinion in Virology (2020) Vol. 44, pp. 112-120
Open Access | Times Cited: 32
Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease
Marcos Nuévalos, Estéfani García‐Ríos, Francisco J. Mancebo, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 5, pp. 480-497
Closed Access | Times Cited: 10
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees
Cody S. Nelson, Diana Vera Cruz, Melody Su, et al.
Journal of Virology (2018) Vol. 93, Iss. 5
Open Access | Times Cited: 31
Alphaherpesvirus Vaccines
Clare Burn Aschner, Betsy C. Herold
Current Issues in Molecular Biology (2020), pp. 469-508
Open Access | Times Cited: 24
Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells
Ranim El Baba, Sandy Haidar Ahmad, Franck Monnien, et al.
Oncogene (2023) Vol. 42, Iss. 41, pp. 3047-3061
Open Access | Times Cited: 7
Development of novel vaccines against human cytomegalovirus
Xinle Cui, Clifford M. Snapper
Human Vaccines & Immunotherapeutics (2019) Vol. 15, Iss. 11, pp. 2673-2683
Open Access | Times Cited: 21
Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants
Sita Awasthi, Lauren M. Hook, Gokul Swaminathan, et al.
Vaccine (2019) Vol. 37, Iss. 29, pp. 3770-3778
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top